Reduced expression of E-cad in breast carcinoma is associated with shortened disease-free survival and high histological grade [43-46], whereas high expression of c-met is associated with more aggressive disease and decreased disease-free survival in node-negative breast cancer [15,47] (see Table 1). Here, CDH1 is linked to breast carcinoma.